<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim M</submitter><funding>BLRD VA</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>U.S. Department of Veterans Affairs</funding><funding>NIGMS NIH HHS</funding><pagination>1284-1294</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9356980</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(8)</volume><pubmed_abstract>Caspase 9 undergoes alternative splicing to produce two opposing isoforms: proapoptotic Caspase 9a and pro-survival Caspase 9b (C9b). Previously, our laboratory reported that C9b is expressed in majority of non-small cell lung cancer tumors and directly activates the NF-κB pathway. In this study, the role of C9b in activation of the NF-κB pathway in vivo, lung inflammation and immune responses, and lung tumorigenesis were examined. Specifically, a transgenic mouse model expressing human C9b in the lung pneumocytes developed inflammatory lung lesions, which correlated with enhanced activation of the NF-κB pathway and increased influx of immunosuppressive myeloid-derived suppressor cells in contrast to wild-type mice. C9b mice presented with facial dermatitis, a thickened and disorganized de</pubmed_abstract><journal>Molecular cancer research : MCR</journal><pubmed_title>Caspase 9b Drives Cellular Transformation, Lung Inflammation, and Lung Tumorigenesis.</pubmed_title><pmcid>PMC9356980</pmcid><funding_grant_id>BX001792</funding_grant_id><funding_grant_id>CA248298</funding_grant_id><funding_grant_id>I01 BX001792</funding_grant_id><funding_grant_id>R01 GM137578</funding_grant_id><funding_grant_id>R37 CA248298</funding_grant_id><funding_grant_id>IK6 BX004603</funding_grant_id><funding_grant_id>GM137578</funding_grant_id><funding_grant_id>IK6BX004603</funding_grant_id><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Uram-Tuculescu C</pubmed_authors><pubmed_authors>Pillappa R</pubmed_authors><pubmed_authors>Chalfant CE</pubmed_authors><pubmed_authors>Vu NT</pubmed_authors><pubmed_authors>Wang MH</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Bulut GB</pubmed_authors><pubmed_authors>Kim M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Caspase 9b Drives Cellular Transformation, Lung Inflammation, and Lung Tumorigenesis.</name><description>Caspase 9 undergoes alternative splicing to produce two opposing isoforms: proapoptotic Caspase 9a and pro-survival Caspase 9b (C9b). Previously, our laboratory reported that C9b is expressed in majority of non-small cell lung cancer tumors and directly activates the NF-κB pathway. In this study, the role of C9b in activation of the NF-κB pathway in vivo, lung inflammation and immune responses, and lung tumorigenesis were examined. Specifically, a transgenic mouse model expressing human C9b in the lung pneumocytes developed inflammatory lung lesions, which correlated with enhanced activation of the NF-κB pathway and increased influx of immunosuppressive myeloid-derived suppressor cells in contrast to wild-type mice. C9b mice presented with facial dermatitis, a thickened and disorganized de</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-03-27T16:27:01.759Z</modification><creation>2025-08-30T03:05:29.008Z</creation></dates><accession>S-EPMC9356980</accession><cross_references><pubmed>35412615</pubmed><doi>10.1158/1541-7786.MCR-21-0905</doi></cross_references></HashMap>